Evaluation of the effectiveness of ellagic acid on patients with non-alcoholic fatty liver disease
Phase 2
Recruiting
- Conditions
- Patients with non-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20180103038199N16
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age between 30-65 years old
Body composition index between 25-35
Diagnosis of liver steatosis by two-dimensional elastography (grade 2 and above)
Fatty liver patients with grade F0 and F1
Exclusion Criteria
Viral hepatitis (especially hepatitis C)
Alcoholic fatty liver or consumption of alcohol
Diseases such as Wilson's disease, hemochromatosis, celiac disease, cirrhosis, biliary obstruction and primary biliary cirrhosis
Special nutritional conditions such as starvation, fasting, and intravenous feeding
Smoker
Breastfeeding or pregnancy
History of hypersensitivity to pomegranate and its products
Diabetes
Taking any kind of herbal supplements
Fatty liver patients with grade F2, F3, F4
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method